{"organizations": [], "uuid": "8230369bd9e2637bb080eeeaf0a48de5a53c904e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-spark-therapeutics-announces-progr/brief-spark-therapeutics-announces-programs-to-improve-patient-access-to-luxturna-idUSFWN1OY0CL", "country": "US", "domain_rank": 408, "title": "BRIEF-Spark Therapeutics Announces Programs To Improve Patient Access To LUXTURNA", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-03T16:03:00.000+02:00", "replies_count": 0, "uuid": "8230369bd9e2637bb080eeeaf0a48de5a53c904e"}, "author": "", "url": "https://www.reuters.com/article/brief-spark-therapeutics-announces-progr/brief-spark-therapeutics-announces-programs-to-improve-patient-access-to-luxturna-idUSFWN1OY0CL", "ord_in_thread": 0, "title": "BRIEF-Spark Therapeutics Announces Programs To Improve Patient Access To LUXTURNA", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "harvard pilgrim", "sentiment": "none"}, {"name": "luxturna reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "January 3, 2018 / 2:03 PM / in 14 minutes BRIEF-Spark Therapeutics Announces Programs To Improve Patient Access To LUXTURNA Reuters Staff 1 Min Read \nJan 3 (Reuters) - Spark Therapeutics Inc: \n* SPARK THERAPEUTICS ANNOUNCES FIRST-OF-THEIR-KIND PROGRAMS TO IMPROVE PATIENT ACCESS TO LUXTURNAâ„¢ (VORETIGENE NEPARVOVEC-RZYL), A ONE-TIME GENE THERAPY TREATMENT \n* SPARK THERAPEUTICS INC - ALSO HAS REACHED AN AGREEMENT IN PRINCIPLE WITH AFFILIATES OF EXPRESS SCRIPTS TO ENABLE INNOVATIVE CONTRACTING MODEL \n* SPARK THERAPEUTICS INC - IN ACTIVE DISCUSSIONS WITH OTHER COMMERCIAL INSURERS REGARDING THE OFFERING \n* SPARK THERAPEUTICS- REACHED DEAL WITH HARVARD PILGRIM TO MAKE LUXTURNA AVAILABLE UNDER OUTCOMES-BASED REBATE ARRANGEMENT & INNOVATIVE CONTRACTING MODEL Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-03T16:03:00.000+02:00", "crawled": "2018-01-03T16:22:07.004+02:00", "highlightTitle": ""}